D-0552-2026 Class III Ongoing

Recalled by Eugia US LLC — East Windsor, NJ

FDA drug recall D-0552-2026 was initiated by Eugia US LLC on May 18, 2026 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan The recall status is ongoing. Affected quantity: 168,300 vials.

Recall details

Product Type
Drugs
Report Date
Jun 10, 2026
Initiation Date
May 18, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
168,300 vials

Product description

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Reason for recall

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Distribution pattern

US Nationwide.

Code information

Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0552-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0552-2026. Report a data issue: hello@regdatalab.com.